Tamtam Try Tamtam free
Green Thumb Industries (GTI) logo

Green Thumb Industries (GTI) account plan

Cannabis products manufacturer and retailer

At a glance

Green Thumb Industries is a Chicago cannabis brand maker and RISE Dispensaries retailer in fourteen U.S. markets with approximately 5,000 employees.

Green Thumb Industries (GTI) is a Chicago-headquartered, vertically integrated cannabis company founded in 2014: it grows and processes cannabis, makes consumer packaged goods in twenty manufacturing facilities and sells them wholesale to licensed dispensaries and through its own RISE Dispensaries. It operates in fourteen U.S. markets, from Illinois, Florida and Pennsylvania to New York, Ohio, Minnesota and Virginia, and employs approximately 5,000 people. FY2025 revenue was $1,175,295 thousand, up 3%, with Adjusted EBITDA of $341,589 thousand and net income attributable to GTI of $114,152 thousand. Its shares trade on the CSE (GTII) and OTCQX (GTBIF), and Super Voting Shares held by Benjamin Kovler, Andrew Grossman and Anthony Georgiadis concentrate voting control.

Business units

Strategic priorities

Retail expansion in Florida and beyond
Twenty-two stores were opened or acquired in the year to September 30, 2026; GTI has 27 Florida dispensaries and plans three to five more in Florida before year end, "10 plus" in Florida next year and one or two in Ohio.
New adult-use and medical markets
Virginia adult-use sales begin July 1, 2027, where GTI is one of five licensed operators with six RISE dispensaries and two cultivation facilities; in Texas it holds a conditional license since April 1 and bought a wholesale facility near Fort Worth.
Federal rescheduling and tax relief
Medical cannabis moved to Schedule III effective April 28, 2026, so Section 280E no longer applies to the medical business; GTI is pursuing DEA registration in Florida and Virginia and awaits the broader rescheduling decision.
Brand leadership in CPG
GTI holds the number one market position in Illinois, Maryland and New Jersey, and its strategic thesis is "that distributing brands at scale will win".
Disciplined capital allocation
Capital goes to growth capex, M&A and buybacks; since Q4 2023 more than $200 million has been returned through about 29.5 million shares repurchased, and a new $50,000 thousand program started September 23, 2026.

Latest results

In Q3 2026 (quarter ended September 30, 2026), revenue rose 11% to $324,412 thousand, driven by Minnesota adult-use, new and acquired stores and growth in Florida, New Jersey, New York, Ohio and Virginia, partly offset by price compression. Gross margin fell to 45% from 49%, mainly because of $15,750 thousand of RYM brand licensing fees, and income from operations dropped 32% to $25,089 thousand. GTI posted a net loss attributable of $4,827 thousand, versus net income a year earlier that included the IP sale gain; Normalized EBITDA rose to $89,402 thousand from $80,163 thousand. Nine-month revenue was $931,285 thousand, up 8%. Management expects Q4 revenue "flat to down slightly due to the pricing environment" and continued margin compression.

Investments and deals

RYTHM, Inc. (RYM) stake and consolidation
GTI owns approximately 33% of RYM, extended it convertible notes of $27,000 thousand (May 2025) and $45,000 thousand (August 2025), and began consolidating it on October 10, 2026 after the 49.99% ownership cap was removed.
Brand IP sale and license-back
In 2025 GTI sold its brand intellectual property to RYM and licenses it back; from April 1, 2026 the revenue-based fee was replaced by fixed annual licensing fees.
Retail acquisitions
Seven retail stores were bought in 2025 for about $19,308 thousand; in the nine months to September 30, 2026 GTI took control of retail operations through management services agreements for total consideration of $62,551 thousand.
Capex
2026 capex is guided at approximately 80 million excluding real estate, with $20 million spent in Q3 2026.
Share buybacks
13,438,787 shares were repurchased in the nine months to September 30, 2026 at a $5.78 average, after 7,209,875 shares in 2025.

Challenges and risks

Price compression
Price compression and competition weighed on both segments, notably in Massachusetts, New Jersey and Pennsylvania; management expects "some continued compression" in coming quarters.
Brand licensing fees squeeze margins
RYM licensing fees of $40,478 thousand in the first nine months of 2026 pushed gross margin to 46% from 50%.
Federal illegality and banking
Broader rescheduling is still pending, Section 280E still applies outside the medical business, banking access is restricted and U.S. multistate operators cannot list on U.S. exchanges.
Competition from hemp-derived THC
Intoxicating hemp products compete with licensed cannabis until a federal law effectively prohibits them; Kovler says "That product has to go away."
Rising operating costs
SG&A reached 38% of revenue in Q3 2026, with normalized operating costs about $88 million vs $75 million, mainly from 22 incremental retail stores.

What leadership says

“Navigating that uncertainty isn't a side skill for us. It's a core competency.”

Ben Kovler, Founder, Chairman and CEO · Q3 2026 earnings call, November 4, 2026

“What institutions need is federal certainty, clarity on scheduling and clarity on taxes.”

Ben Kovler, Founder, Chairman and CEO · Q3 2026 earnings call, November 4, 2026

“Medical cannabis is now on Schedule III of the controlled substances act, the first domino has fallen.”

Ben Kovler, Founder, Chairman and CEO · Q2 2026 earnings call, August 4, 2026

“We build brands people love, invest in our team, and protect the balance sheet.”

Ben Kovler, Founder, Chairman and CEO · Q3 2026 earnings call, November 4, 2026

Where a supplier can help

Store build-out and fit-out
The retail expansion priority ("10 plus" Florida stores next year, Ohio openings) creates demand for store construction, fixtures, security and point-of-sale systems.
Cultivation and processing capacity
Virginia adult-use from July 1, 2027 and the Texas wholesale hub need added cultivation, extraction and packaging capacity, within about 80 million of 2026 capex.
Retail cost efficiency
Rising operating costs from 22 incremental stores and continued price compression make workforce scheduling, inventory and pricing tools relevant to protecting margins.
Compliance and DEA registration
The rescheduling priority and DEA registration of medical operations in Florida and Virginia call for regulatory compliance, tracking and tax advisory support.
Finance integration of RYTHM
Consolidating RYM from October 10, 2026 as a business combination achieved in stages requires accounting, valuation and systems integration work.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Green Thumb Industries (GTI)?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Green Thumb Industries (GTI)

What does Green Thumb Industries do?

Green Thumb grows and processes cannabis, manufactures branded products such as RYTHM, Dogwalkers and incredibles, and sells them wholesale and through its RISE Dispensaries in fourteen U.S. markets.

What is Green Thumb Industries' revenue?

FY2025 revenue was $1,175,295 thousand, up 3%. Q3 2026 revenue was $324,412 thousand, up 11%.

How many employees does Green Thumb have?

Green Thumb employs approximately 5,000 people, including approximately 2,500 in retail and approximately 2,000 in cultivation and processing.

Who leads Green Thumb Industries?

Benjamin Kovler is Founder, Chairman and CEO, Anthony Georgiadis is President and Mathew Faulkner is CFO.

How many stores does Green Thumb operate?

GTI had 130 open and operating Retail stores at September 30, 2026, up from 108 a year earlier, mostly under the RISE Dispensaries name.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)